These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 9730428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V, Bartsch D, Wunsch A, Möllenbeck P, Golda T, Viebahn R, Grosse-Wilde H.
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K, John R, Burke E, Schuster M, Rogers TB, Suciu-Foca N, Mancini D, Itescu S.
    Circulation; 2005 Oct 18; 112(16):2468-76. PubMed ID: 16230499
    [Abstract] [Full Text] [Related]

  • 8. Immunologic sensitization in recipients of left ventricular assist devices.
    John R, Lietz K, Schuster M, Naka Y, Rao V, Mancini DM, Rose EA, Smith CR, Oz MC, Edwards NM, Itescu S.
    J Thorac Cardiovasc Surg; 2003 Mar 18; 125(3):578-91. PubMed ID: 12658200
    [Abstract] [Full Text] [Related]

  • 9. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
    Chu KE, Ho EK, de la Torre L, Vasilescu ER, Marboe CC.
    Cardiovasc Pathol; 2005 Mar 18; 14(4):219-24. PubMed ID: 16009321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM, París SC, Arbeláez M, Cotes JM, Süsal C, Torres Y, García LF.
    Hum Immunol; 2007 Aug 18; 68(8):652-60. PubMed ID: 17678719
    [Abstract] [Full Text] [Related]

  • 14. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C, Döhler B, Opelz G.
    Hum Immunol; 2009 Aug 18; 70(8):569-73. PubMed ID: 19375472
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P, Brink J, Kahn D.
    Clin Transplant; 1997 Apr 18; 11(2):134-8. PubMed ID: 9113450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.